AF
Andrew Fein HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
182
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
95.3%
Neutral
4.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $75 |
179%
upside
| 5 | -3.1% |
0
%
| 12 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $68 |
39%
upside
| 5 | +13% |
0
%
| 12 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $10 |
212%
upside
| 3 | +34% |
0
%
| 9 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $38 |
127%
upside
| 6 | -6% |
0
%
| 9 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $16 |
5%
upside
| 4 | +56% |
0
%
| 9 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $25 |
62%
upside
| 5 | -15% |
0
%
| 8 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $32 |
89%
upside
| 4 | -11% |
0
%
| 7 May ‘25 5 months ago |
|
|
|
Buy
Reiterated
| $30 |
329%
upside
| 2 | -1.8% |
0
%
| 6 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $16 |
0%
upside
| 2 | +121% |
0
%
| 5 May ‘25 5 months ago |
|
|
|
Buy
Reiterated
| $135 |
4%
upside
| 4 | +10% |
0
%
| 2 May ‘25 5 months ago |
|
|
|
Buy
Maintained
| $12 |
330%
upside
| 5 | +1.9% |
0
%
| 1 May ‘25 5 months ago |
|
|
|
Buy
Reiterated
| $8 |
228%
upside
| 2 | -11% |
0
%
| 28 Apr ‘25 5 months ago |
|
|
|
Buy
Maintained
| $168 |
18%
upside
| 7 | +4.2% |
0
%
| 22 Apr ‘25 6 months ago |
|
|
|
Buy
Maintained
| $7 |
36%
upside
| 2 | +285% |
0
%
| 4 Apr ‘25 6 months ago |
|
|
|
Buy
Maintained
| $11 |
456%
upside
| 2 | +3.4% |
0
%
| 28 Mar ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $10 |
510%
upside
| 4 | -18% |
0
%
| 27 Mar ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $2 |
67%
upside
| 2 | -72% |
0
%
| 17 Mar ‘25 7 months ago |
|
|
|
Buy
Maintained
| $12 |
307%
upside
| 3 | +5.2% |
0
%
| 14 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $13 |
219%
upside
| 2 | -14% |
0
%
| 7 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $11 |
59%
upside
| 3 | +5.3% |
0
%
| 6 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $23 |
326%
upside
| 3 | +44% |
0
%
| 6 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $15 |
541%
upside
| 3 | -17% |
0
%
| 6 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $85 |
10%
downside
| 4 | +24% |
0
%
| 3 Mar ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $35 |
63%
upside
| 3 | -2.7% |
0
%
| 28 Feb ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $75 |
287%
upside
| 2 | +56% |
0
%
| 18 Feb ‘25 8 months ago |
|